Inqovi OverviewDecitabine/cedazuridine, sold under the brand name Inqovi, is a fixed-dosed combination medication for the treatment of adults with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). It is a combination of decitabine, a nucleoside metabolic inhibitor, and cedazuridine, a cytidine deaminase inhibitor. The most common side effects of decitabine/cedazuridine ...
Read more Inqovi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Decitabine/cedazuridine
Recent Inqovi Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Decitabine + Cedazuridine
- Tablet: 100mg + 35mg, 35mg + 100mg
NDC Database Records for Inqovi: (1 result)Sorted by National Drug Code
- 64842-0727 Inqovi Oral Tablet, Film Coated by Taiho Pharmaceutical Co., Ltd.